We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy


Metabolite ID/Characterization Studies FAQ

Video   Jan 13, 2021


Presenter: Mark Horrigan, SEKISUI XenoTech Study Director

In this short, information-packed ADME 101 video, one of the principal scientists in our program oversight department discusses the main frequently asked questions that we receive about metabolite identification and characterization studies.

Major topics of the presentation include:
- Met ID in Drug Development
- Definitions
- Regulatory expectations
- In vitro test systems
- In vivo studies
- Radiolabeled vs cold test article
- Quantitative information
- Interpretation of results

About the presenter: Mark Horrigan joined SEKISUI XenoTech in 2005 as a Senior Mass Spectrometry Specialist and Qualitative Analysis group leader. Since then he has served as a Principal Scientist in the Drug Metabolism and Program Oversight Departments.

Download a copy of the slides: https://www.xenotech.com/webinar-slides/sekisui-xenotech_metabolite-id-characterization_ad?emat=121LT
Questions, comments and requests: https://www.xenotech.com/contact/?emat=121LT
More information on our research services and test systems: https://www.xenotech.com/?emat=121LT
Other previously aired webinars: https://www.xenotech.com/access-adme-research-resources/resource-type/webinar/?emat=121LT
Upcoming webinar notifications: https://www.xenotech.com/contact/newsletter-sign-up/?emat=121LT
Request a webinar topic: https://www.xenotech.com/contact/webinar-seminar-request/?emat=121LT

More Information

Request Information


Recommended Videos

COVID, One Year Later: What Do We Know Now?


ACS Reactions catch up with experts they talked to at the start of the pandemic and ask, "what do we know now that we didn’t back then?"


Your COVID-19 Vaccine Questions Answered


Millions of people are now being immunized with the new Pfizer/BioNTech and Moderna mRNA vaccines. Are they effective? Are they safe? Infectious disease and global health expert Carlos del Rio, MD, of Emory University answers your questions.


How Can We Find New Drugs To Treat COVID-19?


Hear from researchers in the Chromosome Replication Laboratory at the Francis Crick Insititute, who have been testing thousands of drugs against SARS-CoV-2 using a biochemical test.



Like what you just watched? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free